What does PTC Therapeutics, Inc. do?

Jun 22 2025 06:44 PM IST
share
Share Via
PTC Therapeutics, Inc. is a biopharmaceutical company focused on developing medicines for rare disorders, with recent net sales of $1.176 billion and a market cap of $4.03 billion. The company has a P/E ratio of 6.00 and no dividend yield.
Overview:
PTC Therapeutics, Inc. is a science-driven global biopharmaceutical company focused on the discovery, development, and commercialization of clinically-differentiated medicines for patients with rare disorders, operating in the Pharmaceuticals & Biotechnology industry within the small-cap market.

Financial Snapshot:
Most recent Net Sales: 1,176 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 867 Million (Quarterly Results - Mar 2025)
Market-cap: USD 4,030.22 Million (Small Cap)

Key Metrics:
P/E: 6.00
Dividend Yield: 0.00%
Debt Equity: 9.29
Return on Equity: -400.08%
Price to Book: -21.70

Contact Details:
Address: 100 Corporate Ct, SOUTH PLAINFIELD NJ: 07080-2400
Tel: 1 908 2227000
Website: https://www.ptcbio.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
PTC Therapeutics Hits New 52-Week High of $69.88, Up 81.1%
Oct 31 2025 04:11 PM IST
share
Share Via
PTC Therapeutics Hits New 52-Week High of $69.26, Up 82.16%
Oct 16 2025 06:15 PM IST
share
Share Via
PTC Therapeutics, Inc. Hits New 52-Week High of $67.40
Oct 06 2025 05:31 PM IST
share
Share Via
Is PTC Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 07:47 PM IST
share
Share Via
Is PTC Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 08:49 AM IST
share
Share Via
Who are in the management team of PTC Therapeutics, Inc.?
Jun 22 2025 10:33 PM IST
share
Share Via